The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy.
Complications
Hospital readmission
Prostate cancer
Radical prostatectomy
Robotic surgery
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
23
09
2019
accepted:
10
01
2020
pubmed:
26
1
2020
medline:
22
6
2021
entrez:
26
1
2020
Statut:
ppublish
Résumé
To evaluate the factors associated with the risk of hospital readmission after robot assisted radical prostatectomy (RARP) with or without extended pelvic lymph node dissection (ePLND) for prostate cancer (PCA) over a long term. The risk of readmission was evaluated by clinical, pathological, and perioperative factors. Skilled and experienced surgeons performed the procedures. Patients were followed for complications and hospital readmission for a period of six months. The logistic regression model and Cox's proportional hazards assessed the association of factors with the risk of readmission. From January 2013 to December 2018, 890 patients underwent RARP; ePLND was performed in 495 of these patients. Hospital readmission was detected in 25 cases (2.8%); moreover, it was more frequent when RARP was performed with ePLND (4.4% of cases) than without (0.8% of patients). On the final multivariate model, ePLND was the only independent factor that was positively associated with the risk of hospital readmission (hazard ratio, HR = 5935; 95%CI 1777-19,831; p = 0.004). Over the long term after RARP for PCA, the risk of hospital readmission is associated with ePLND. In patients who underwent RARP and ePLND, 4.4% of them had a readmission, compared to RARP alone, in which only 0.8% of cases had a readmission. When ePLND is planned for staging pelvic lymph nodes, patients should be informed of the increased risk of hospital readmission.
Identifiants
pubmed: 31980875
doi: 10.1007/s00345-020-03094-2
pii: 10.1007/s00345-020-03094-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2799-2809Références
Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618–629
doi: 10.1016/j.eururo.2016.08.003
Artibani W, Porcaro AB, De Marco V, Cerruto MA, Siracusano S (2018) Management of biochemical recurrence after primary curative treatment for prostate cancer: a review. Urol Int 100:251–262
doi: 10.1159/000481438
Mitropoulos D, Artibani W, Graefen M, Remzi M, Roupret M, Truss M (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 61:341–349
doi: 10.1016/j.eururo.2011.10.033
Menon MA, Tewari J, Peabody J, VIP Team (2003) Vattikuti Institute prostatectomy technique. J Urol 169: 2289–2292
Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61:480–487
doi: 10.1016/j.eururo.2011.10.044
Porcaro AD, Inverardi P, Corsi M, Sebben G, Cacciamani A, Tafuri T, Processali M, Pirozzi D, Mattevi D, Marchi D (2018) Prostate specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low risk prostate cancer. Minerva Urol Nefrol. https://doi.org/10.23736/S0393-2249.18.03172-7
doi: 10.23736/S0393-2249.18.03172-7
Porcaro AB, Cavicchioli F, Mattevi D, De Luyk N, Corsi P, Sebben M, Tafuri A, Processali T, Cerasuolo M, Tamanini I (2017) Clinical factors of disease reclassification or progression in a contemporary cohort of prostate cancer patients elected to active surveillance. Urol Int 98:32–39
doi: 10.1159/000452631
Porcaro AB, de Luyk N, Corsi P, Sebben M, Tafuri A, Mattevi D, Processali T, Cerruto MA, Brunelli M, Antoniolli SZ (2017) Clinical factors predicting and stratifying the risk of lymph node invasion in localized prostate cancer. Urol Int 99:207–214
doi: 10.1159/000458763
Porcaro AB, De Luyk N, Corsi P, Sebben M, Tafuri A, Processali T, Cerasuolo M, Mattevi D, Cerruto MA, Brunelli M (2017) Association between basal total testosterone levels and tumor upgrading in low and intermediate risk prostate cancer. Urol Int 99:215–221
doi: 10.1159/000459632
Porcaro AB, Siracusano S, Luyk Nd, Corsi P, Sebben M, Tafuri A, Processali T, Cerasuolo M, Mattevi D, Inverardi D (2018) Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer. Tumori J 104:111–115
doi: 10.5301/tj.5000580
Porcaro AB, Tafuri A, Sebben M, Corsi P, Pocessali T, Pirozzi M, Amigoni N, Rizzetto R, Mariotto A, Inverardi D, Brunelli M, Iacovelli R, Romano M, Siracusano S, Artibani W (2018) Positive association between preoperative total testosterone levels and risk of positive surgical margins by prostate cancer: results in 476 consecutive patients treated only by radical prostatectomy. Urol Int 101:38–46
doi: 10.1159/000490622
Porcaro AB, Cacciamani GE, Sebben M, Tafuri A, Processali T, Rizzetto R, De Luyk N, Pirozzi M, Amigoni N, Corsi P, Inverardi D, Brunelli M, Migliorini F, De Marco V, Artibani W (2019) Lymph nodes invasion of marcille’s fossa associates with high metastatic load in prostate cancer patients undergoing extended pelvic lymph node dissection: the role of “Marcillectomy”. Urol Int Urol Int 103:25–32
doi: 10.1159/000500330
Cacciamani GE, Porcaro AB, Sebben M, Tafuri A, Rizzetto R, De Luyk N, Ciocchetta E, Processali T, Pirozzi M, Amigoni N, Corsi P, Brunelli M, De Marco V, Artibani W (2019) Extended pelvic lymphadenectomy for prostate cancer: should the Cloquet’s nodes dissection be considered only an option? Minerva Urol Nefrol 71:136–145
Porcaro AB, Tafuri A, Sebben M, Novella G, Processali T, Pirozzi M, Amigoni N, Rizzetto R, Shakir A, Mariotto A, Brunelli M, Cerruto MA, Cacciamani GE, Migliorini F, Siracusano S, Artibani W (2019) Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy. World J Urol. https://doi.org/10.1007/s00345-019-02830-7
doi: 10.1007/s00345-019-02830-7
Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 40:244–252
Srigley JR, Humphrey PA, Amin MB, Chang SS, Egevad L, Epstein JI, Grignon DJ, McKiernan JM, Montironi R, Renshaw AA, Reuter VE, Wheeler TM (2009) Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med 133:1568–1576
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
doi: 10.1097/01.sla.0000133083.54934.ae
Pilecki MA, McGuire BB, Jain U, Kim JY, Nadler RB (2014) National multi-institutional comparison of 30-day postoperative complication and readmission rates between open retropubic radical prostatectomy and robot-assisted laparoscopic prostatectomy using NSQIP. J Endourol 28:430–436
doi: 10.1089/end.2013.0656
Brito J 3rd, Pereira J, Moreira DM (2018) The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). Prostate Cancer Prostatic Dis 21:245–251
doi: 10.1038/s41391-018-0051-z
Chung SD, Kelle JJ, Huang CY, Chen YH, Lin HC (2012) Comparison of 90-day re-admission rates between open retropubic radical prostatectomy (RRP), laparoscopic RP (LRP) and robot-assisted laparoscopic prostatectomy (RALP). BJU Int 110:E966–E971
doi: 10.1111/j.1464-410X.2012.11183.x
Friethriksson JO, Holmberg E, Adolfsson J, Lambe M, Bill-Axelson A, Carlsson S, Hugosson J, Stattin P (2014) Rehospitalization after radical prostatectomy in a nationwide, population based study. J Urol 192:112–119
doi: 10.1016/j.juro.2014.01.109
Gandaglia G, Bravi CA, Dell'Oglio P, Mazzone E, Fossati N, Scuderi S, Robesti D, Barletta F, Grillo L, Maclennan S, N'Dow J, Montorsi F, Briganti A (2018) The Impact of Implementation of the european association of urology guidelines panel recommendations on reporting and grading complications on perioperative outcomes after robot-assisted radical prostatectomy. Eur Urol 74:4–7
doi: 10.1016/j.eururo.2018.02.025
Moschini M, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Luzzago S, Zaffuto E, Suardi N, Damiano R, Shariat SF, Montorsi F, Briganti A (2017) Incidence and predictors of 30-Day readmission after robot-assisted radical prostatectomy. Clin Genitourin Cancer 15:67–71
doi: 10.1016/j.clgc.2016.06.002
Wallerstedt Lantz A, Stranne J (2019) 90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery. Scand J Urol 53:26–33
doi: 10.1080/21681805.2018.1556729
Xia L, Taylor BL, Pulido JE, Mucksavage P, Lee DI, Guzzo TJ (2017) Predischarge predictors of readmissions and postdischarge complications in robot-assisted radical prostatectomy. J Endourol 31:864–871
doi: 10.1089/end.2017.0293
Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Dunglison N, Carter R, Williams S, Payton DJ, Perry-Keene J, Lavin MF, Gardiner RA (2016) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 388:1057–1066
doi: 10.1016/S0140-6736(16)30592-X
Fracalanza S, Ficarra V, Cavalleri S, Galfano A, Novara G, Mangano A, Plebani M, Artibani W (2008) Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Results from a prospective, unrandomized, comparative study. BJU Int 101:1145–1149
doi: 10.1111/j.1464-410X.2008.07513.x
Porcaro AB, de Luyk N, Corsi P, Sebben M, Tafuri A, Inverardi D, De Marchi D, Tamanini I, Brunelli M, Cerruto MA, Salvagno GL, Guidi GC, Artibani W (2016) Robotic assisted radical prostatectomy accelerates postoperative stress recovery: Final results of a contemporary prospective study assessing pathophysiology of cortisol peri-operative kinetics in prostate cancer surgery. Asian J Urol 3:88–95
doi: 10.1016/j.ajur.2016.03.002
Porcaro AB, Molinari A, Terrin A, De Luyk N, Baldassarre R, Brunelli M, Cavalleri S, Cerruto MA, Gelati M, Salvagno GL, Guidi GC, Artibani W (2015) Robotic-assisted radical prostatectomy is less stressful than the open approach: results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery. J Robot Surg 9:249–255
doi: 10.1007/s11701-015-0522-3
Porcaro AB, Sebben M, Corsi P, Tafuri A, Processali T, Pirozzi M, Amigoni N, Rizzetto R, Cacciamani G, Mariotto A, Diminutto A, Brunelli M, De Marco V, Siracusano S, Artibani W (2019) Risk factors of positive surgical margins after robot-assisted radical prostatectomy in high-volume center: results in 732 cases. J Robot Surg. https://doi.org/10.1007/s11701-019-00954-x
doi: 10.1007/s11701-019-00954-x
Porcaro AB, Sebben M, Tafuri A, de Luyk N, Corsi P, Processali T, Pirozzi M, Rizzetto R, Amigoni N, Mattevi D, Cerruto MA, Brunelli M, Novella G, De Marco V, Migliorini F, Artibani W (2019) Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection. J Robot Surg 13:83–89
doi: 10.1007/s11701-018-0824-3
Porcaro AB, Tafuri A, Sebben M, Processali T, Pirozzi M, Amigoni N, Rizzetto R, Shakir A, Cacciamani GE, Brunelli M, Siracusano S, Cerruto MA, Artibani W (2019) Body Mass Index and prostatic specific antigen are independent predictors of multiple prostate cancer lymph node metastases in Caucasian patients undergoing robot assisted radical prostatectomy and extended pelvic lymph node dissection. Minerva Urol Nefrol 71:516–523
doi: 10.23736/S0393-2249.19.03401-5
Porcaro AB, Tafuri A, Sebben M, Processali T, Pirozzi M, Amigoni N, Rizzetto R, Shakir A, Cerruto MA, Brunelli M, Siracusano S, Artibani S (2019) High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection. Asian J Androl
Gotto GT, Yunis LH, Guillonneau B, Touijer K, Eastham JA, Scardino PT, Rabbani F (2011) Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection. Int J Urol 18:291–296
doi: 10.1111/j.1442-2042.2010.02710.x
Tikkinen KAO, Craigie S, Agarwal A, Violette PD, Novara G, Cartwright R, Naspro R, Siemieniuk RAC, Ali B, Eryuzlu L, Geraci J, Winkup J, Yoo D, Gould MK, Sandset PM, Guyatt GH (2018) Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: systematic review and meta-analysis. Eur Urol 73:242–251
doi: 10.1016/j.eururo.2017.03.008
Klaassen Z, Wallis CJD, Lavallee LT, Violette PD (2019) Perioperative venous thromboembolism prophylaxis in prostate cancer surgery. World J Urol. https://doi.org/10.1007/s00345-019-02705-x
doi: 10.1007/s00345-019-02705-x
Fukuda H, Yamada T, Kamata S, Saitoh H (2000) Anatomic distribution of intraprostatic lymphatics: implications for the lymphatic spread of prostate cancer-a preliminary study. Prostate 44:322–327
doi: 10.1002/1097-0045(20000901)44:4<322::AID-PROS9>3.0.CO;2-8
Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1990) Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 143:1183–1187
doi: 10.1016/S0022-5347(17)40220-5
Gil-Vernet JM (1996) Prostate cancer: anatomical and surgical considerations. Br J Urol 78:161–168
doi: 10.1046/j.1464-410X.1996.00841.x
Porcaro AB, de Luyk N, Corsi P, Sebben M, Tafuri A, Tamanini I, Processali T, Cerruto MA, Migliorini F, Brunelli M, Siracusano S, Artibani W (2017) Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer. Tumori 103:299–306
doi: 10.5301/tj.5000546
Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie A (2012) Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol 62:368–381
doi: 10.1016/j.eururo.2012.05.057